Immune Correlates of COVID-19 Control

by Bhawna Poonia, Shyam Kottilil
Published 2020-09-01

Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics

by Arshi Khanam, Shyam Kottilil
Published 2020-10-01

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression

by Arshi Khanam, Joel V. Chua, Shyam Kottilil
Published 2021-05-01

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?

by Arshi Khanam, Paul G. Saleeb, Shyam Kottilil
Published 2021-05-01

Lymphocyte Landscape after Chronic <i>Hepatitis C Virus</i> (HCV) Cure: The New Normal

by Alip Ghosh, Sara Romani, Shyam Kottilil, Bhawna Poonia
Published 2020-10-01

IL-21–Deficient T Follicular Helper Cells Support B Cell Responses Through IL-27 in Patients With Chronic Hepatitis B

by Arshi Khanam, Natarajan Ayithan, Lydia Tang, Bhawna Poonia, Shyam Kottilil
Published 2021-01-01

MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.

by Xiaozhen Zhang, Marybeth Daucher, David Armistead, Rodney Russell, Shyam Kottilil
Published 2013-01-01

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection

by Cody Orr, Wenjie Xu, Henry Masur, Shyam Kottilil, Eric G. Meissner
Published 2020-12-01

Evolution of Nipah Virus Infection: Past, Present, and Future Considerations

by Naomi Hauser, Alexis C. Gushiken, Shivakumar Narayanan, Shyam Kottilil, Joel V. Chua
Published 2021-02-01

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C

by L. Tang, M. Kamat, A. Shukla, M. Vora, C. Kalal, S. Kottilil, S. Shah
Published 2018-01-01

Peripheral PD-1+ T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection

by Sara Romani, Kristen Stafford, Amy Nelson, Shashwatee Bagchi, Shyam Kottilil, Bhawna Poonia
Published 2019-06-01

On-Treatment Elevation in Hepatic Transaminases during HCV Treatment with Ombitasvir, Paritaprevir, Dasabuvir, Ritonavir, and Ribavirin: A Case Series

by Madelyne Bean, Lydia Tang, Shyam Kottilil, Kimberly L. Beavers, Eric G. Meissner
Published 2016-01-01

Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C

by Katsounas Antonios, Trippler Martin, Kottilil Shyam, Lempicki Richard A, Gerken Guido, Schlaak Joerg F
Published 2012-05-01

Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis

by Jennifer Wellington, Andrew Ma, Shyam Kottilil, Bharath Ravichandran, Jennifer Husson, David Bruno, Eleanor Wilson
Published 2021-09-01

Advances in hepatitis B therapeutics

by Vicente Soriano, Pablo Barreiro, Edward Cachay, Shyamasundaran Kottilil, José V. Fernandez-Montero, Carmen de Mendoza
Published 2020-10-01

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.

by Eric G Meissner, Jérémie Decalf, Armanda Casrouge, Henry Masur, Shyam Kottilil, Matthew L Albert, Darragh Duffy
Published 2015-01-01

Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.

by Emily Comstock, Cheol-Woo Kim, Alison Murphy, Benjamin Emmanuel, Xi Zhang, Michael Sneller, Bhawna Poonia, Shyamasundaran Kottilil
Published 2017-01-01

CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro.

by Jason T Blackard, Ling Kong, Susan D Rouster, Rebekah Karns, Paul S Horn, Shyam Kottilil, M Tarek Shata, Kenneth E Sherman
Published 2019-01-01

Follicular Helper T (TFH) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients

by Natarajan Ayithan, Lydia Tang, Susanna K. Tan, Diana Chen, Jeffrey J. Wallin, Simon P. Fletcher, Shyam Kottilil, Bhawna Poonia
Published 2021-08-01

Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus

by Shikha Shrivastava, Manasa Bhatta, Haley Ward, Sara Romani, Rebecca Lee, Elana Rosenthal, Anu Osinusi, Anita Kohli, Henry Masur, Shyam Kottilil, Eleanor Wilson
Published 2018-12-01